Federal Register / Vol. 66, No. 85 / Wednesday, May 2, 2001 / Notices 21995

552b(c)(4) and 552 (c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel, SBIR

Phase II: ‘‘HIV Risk Assessment for Women

in a Health Care Setting’’.

Date: May 4, 2001.

Time: 11 a.m. to 2 p.m.

Agenda: To review and evaluate contract

proposals.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Rockville, MD 20852, (Telephone Conference

Call).

Contact Person: Richard C. Harrison, Chief,

Contract Review Branch, Office of Extramural

Affairs, National Institute of Drug Abuse,

National Institutes of Health, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, 301–435–1437.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel

‘‘Development and Manufacture of

Pharmaceutical Products for Addiction

Treatment’’.

Date: May 10, 2001.

Time: 10 a.m. to 12 p.m.

Agenda: To review and evaluate contract

proposals.

Place: Neuroscience Center, National

Institutes of Health, 6001 Executive Blvd.,

Rockville, MD 20852, (Telephone Conference

Call).

Contact Person: Eric Zatman, Contract

Review Specialist, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, DHHS, 6001

Executive Boulevard, Room 3158, MSC 9547,

Bethesda, MD 20892–9547, (301) 435–1438.

Name of Committee: National Institute on

Drug Abuse Special Emphasis Panel ‘‘State

and Local Epidemiology Planning and

Information Development’’.

Date: May 22, 2001.

Time: 9 a.m. to 5 p.m.

Agenda: To review and evaluate contract

proposals.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, MD 20814.

Contact Person: Richard C. Harrison, Chief,

Contract Review Branch, Office of Extramural

Affairs, National Institute on Drug Abuse,

National Institutes of Health, 6001 Executive

Boulevard, Room 3158, MSC 9547, Bethesda,

MD 20892–9547, 301–435–1437.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.277, Drug Abuse Scientist

Development Award for Clinicians, Scientist

Development Awards, and Research Scientist

Awards; 93.278, Drug Abuse National

Research Service Awards for Research

Training; 93.279, Drug Abuse Research

Programs, National Institutes of Health, HHS)

Dated: April 25, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–10929 Filed 5–1–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings.

The meetings will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: May 1, 2001.

Time: 1 p.m. to 1:30 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Alexander D. Politis, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4204,

MSC 7812, Bethesda, MD 20892, (301) 435–

1225, politis@mail.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: May 25, 2001.

Time: 10:30 a.m. to 11:30 a.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Zakir Bengali, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5150,

MSC 7842, Bethesda, MD 20892, (301) 435–

1742.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333,

93.337, 93.393–93.396, 93.837–93.844,

93.846–93.878, 93.892, 93.893, National

Institutes of Health, (HHS)

Dated: April 25, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–10923 Filed 5–1–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: April 30, 2001.

Time: 1 p.m. to 2 p.m.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Sally Ann Amero, PhD,

Scientific Reveiw Administrator, Center for

Scientific Review, Genetic Sciences

Integrated Review Group, National Institutes

of Health, 6701 Rockledge Drive, Room 2206,

MSC 7890, Bethesda, MD 20892–7890, 301–

435–1159, ameros@csr.nih.gov

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333,

93.337, 93.393–93.396, 93.837–03.844,

93.846–93.878, 93.892, 93.893, National

Institutes of Health, HHS)

Dated: April 25, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–10930 Filed 5–1–01; 8:45 am]

BILLING CODE 4140–01–M